Phase 3 Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with glioblastoma or grade 4 astrocytoma, confirmed by a pathology (laboratory) test
- People between the ages of 18 and 75 years old
- People who have had surgery to remove (resect) the tumour
- People who are scheduled to receive radiation and chemotherapy together, or chemotherapy alone as their next treatment
- People who have given their written consent to participate in the trial
Who may not be able to join:
- People who have not given their consent to take part in the trial
- People who have an allergy to egg yolk
- People who only had a surgical biopsy (a small sample taken) rather than surgery to remove the tumour
- People who are only scheduled to receive radiation therapy, without chemotherapy
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Charlotte Edwardsson, Skane University Hospital
Phone: +4646171274
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.